ANAB
Anaptysbio, Inc.
Clinical-stage biotechnology company focused on immunology therapeutics
CUSIP: 032724106HealthcareUS1 holder
Total Value
$20.16M
Total Shares
576.2K
Net Share Change
-223.7K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$20.16M576.2K shares
TRIM-223.7K(-28.0%)